-
Mashup Score: 0
A phase 2 clinical trial (NCT04558346) of ghrelin (OXE103; Oxeia Biopharmaceuticals, San Diego, CA) for treating concussions has been initiated. The c
Source: Practical NeurologyCategories: Latest Headlines, NeurologyTweet
-
Mashup Score: 7
The hormone ghrelin has been discovered to be a key regulator of new nerve cells in the adult brain, and may lead to new treatments for Parkinson’s disease.
Categories: Future of Medicine, Latest HeadlinesTweet
-
Mashup Score: 1The GPCR accessory protein MRAP2 regulates both biased signaling and constitutive activity of the ghrelin receptor GHSR1a - 4 year(s) ago
Ghrelin is a peptide that is secreted by the stomach during fasting to promote food intake. The accessory protein MRAP2 interacts with the ghrelin receptor GHSR1a and is important for the orexigenic effects of ghrelin. Rouault et al. found that MRAP2 promoted biased signaling downstream of ghrelin-mediated activation of GHSR1a by inhibiting β-arrestin recruitment to the receptor and potentiating…
Source: Science SignalingCategories: Future of MedicineTweet
-
Mashup Score: 7The GPCR accessory protein MRAP2 regulates both biased signaling and constitutive activity of the ghrelin receptor GHSR1a - 4 year(s) ago
Ghrelin is a peptide that is secreted by the stomach during fasting to promote food intake. The accessory protein MRAP2 interacts with the ghrelin receptor GHSR1a and is important for the orexigenic effects of ghrelin. Rouault et al. found that MRAP2 promoted biased signaling downstream of ghrelin-mediated activation of GHSR1a by inhibiting β-arrestin recruitment to the receptor and potentiating…
Source: Science SignalingCategories: Future of MedicineTweet
#Ghrelin Advances to a Phase 2 Trial for #Concussion Treatment #neurology #PracticalNeurology https://t.co/6q0oSd9SU9